
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Cellectar Biosciences is focused on the discovery and development of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The companys core objective is to leverage its proprietary Phospholipid Drug ConjugateTM (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The companys PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations. The companys product pipeline...
Pdc cancer therapeutics and diagnostics,targeted delivery of oncologic payloads,early-stage chemotherapeutic drug conjugates,and hematologic malignancies
Cellectar biosciences, inc operates in the Biotechnology industry.
Cellectar biosciences, inc's revenue is 11m - 100m
Cellectar biosciences, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.